Trial Profile
The effect of Liraglutide treatment on postprandial chylomicron and VLDL kinetics, liver fat and de novo lipogenesis. A single-center randomized controlled study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Apr 2022
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Pharmacokinetics; Therapeutic Use
- Acronyms LIRA
- 07 Mar 2019 Status changed from active, no longer recruiting to completed.
- 24 Jan 2018 Planned End Date changed from 1 Dec 2020 to 1 Dec 2022.
- 24 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2022.